Health

Why eating garlic could help fight pneumonia, cystic fibrosis, bone infections

Scientists have claimed that deadly bacterial infections that cause chronic conditions like cystic fibrosis, pneumonia and the superbug MRSA, can be fought off by eating garlic.

According to the researchers rom the University of Copenhagen, garlic contains the important sulphurous compound ‘ajoene’, which stopped the Staphylococcus aureus and Pseudomonas aeruginosa bacteria from working.

The bacteria are known to cause lung condition cystic fibrosis, as well as pneumonia, bone infections, and sepsis.

One of the bacteria can also cause endocarditis – a heart valve infection – which leads to heart failure and strokes.

Daily Express quotes researcher Tim Jakobsen as saying that the garlic compound is able to fight both types of bacteria at once and therefore may prove an effective drug when used together with antibiotics.”

The garlic compound stopped molecules inside the bacteria from working, the researchers said.

They also found it can break down the bacteria’s ‘biofilm’ – a shield that protects them from antibiotics and the body’s immune system.

But, it was unclear how much garlic would be needed to fight off the bacteria in humans.

Now, they will test how the extracts help to reduce bacterial infection symptoms in humans, and how much of it will be needed.

“We really believe this method can lead to treatment of patients, who otherwise have poor prospects,” added Jakobsen.

“Chronic infections like cystic fibrosis can be very robust.

“But now we, together with a private company, have enough knowledge to further develop the garlic drug and test it on patients.”

Previous studies claimed garlic offered the most powerful, naturally-occurring resistance to bacteria, the scientists said.

The bacteria can cause serious and fatal infections, according to the Centers for Disease Control and Prevention.

Those most at risk of infection include those suffering from diabetes, cancer, vascular disease, eczema and lung disease.

Comments
To Top